In This Store
Category:API Equipment
Product Name:Fulvestrant Injection
CAS No.:129453-61-8
Standard:USP, EP, In-house Standards
Price(USD):Negotiable
Company:Chia Tai Tianqing Pharmaceutical Group
Co., Ltd.
Grade: Injection Grade
Factory Location: No. 369, South Yuzhou Rd. Lianyungang, Jiangsu, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: L/L
Fulvestrant injection, an injection for intramuscular administration,
is supplied as 250 mg/5 mL fulvestrant.
It is an an estrogen receptor antagonist indicated
for the treatment of:
· Hormone receptor (HR)-positive advanced breast cancer in
postmenopausal women with disease progression following
endocrine therapy. (1)
· HR-positive, HER2-negative advanced or metastatic breast
cancer in postmenopausal women in combination with
ribociclib, as initial endocrine based therapy or following
disease progression on endocrine therapy. (1)
· HR-positive, HER2-negative advanced or metastatic breast
cancer in combination with palbociclib or abemaciclib in
women with disease progression after endocrine therapy
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us: